# Impact of Medical and Surgical Therapy on Functional Mitral Regurgitation

> **NCT00224809** · NA · COMPLETED · sponsor: **Baylor Research Institute** · enrollment: 250 (estimated)

## Conditions studied

- Cardiovascular Diseases
- Heart Diseases
- Coronary Disease

## Interventions

- **DRUG:** Angiotensin-Converting Enzyme Inhibitors
- **PROCEDURE:** Coronary Artery Bypass Graft
- **DRUG:** Angiotensin Receptor Blockers
- **DRUG:** Spironolactone
- **DRUG:** Aspirin
- **DRUG:** Clopidogrel
- **PROCEDURE:** Surgical Ventricular Restoration

## Key facts

- **NCT ID:** NCT00224809
- **Lead sponsor:** Baylor Research Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-09
- **Primary completion:** —
- **Final completion:** 2007-05
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2014-02-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00224809

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00224809, "Impact of Medical and Surgical Therapy on Functional Mitral Regurgitation". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00224809. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*